Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Neovascularization inhibitors disclosed by Takeda

Oct. 30, 1997

Bicalutamide + LHRH-A vs. flutamide + LHRH-A for metastatic prostate cancer

Oct. 29, 1997

Banyu discloses protein farnesyltransferase inhibitors

Oct. 29, 1997

Biomeasure discloses protein farnesyltranserase inhibitors

Oct. 29, 1997

Antitumor effects of Techniclone's LYM-2 reported

Oct. 29, 1997

Research team identifies effector of morphological changes during apoptosis

Oct. 28, 1997

Oxford BioMedica acquires novel anticancer technology

Oct. 28, 1997

Endorex raises funds for clinical testing of antitumor drugs

Oct. 28, 1997

Preclinical studies on FK-317 presented at cancer meeting

Oct. 28, 1997

DAB-720: a new EGF receptor TK inhibitor from Mitsubishi Chemical

Oct. 28, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 28, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Sichuan Kelun Pharmaceutical Research Institute discovers GPR6 inverse agonists
BioWorld Science
Sichuan Kelun Pharmaceutical Research Institute Co. Ltd. has identified G protein-coupled receptor 6 (GPR6) inverse agonists reported to be useful for the...
Grace Therapeutics hits CRL setback with GTx-104 despite positive trial
BioWorld
Grace Therapeutics Inc.’s hopes of becoming the first company in decades to update the standard of care in aneurysmal subarachnoid hemorrhage were delayed after...